Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
about
Possible importance of macrophage-derived mediators in acute malariaBeneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats.The meningococcus and mechanisms of pathogenicityThromboxane A2 mediates lung vasoconstriction but not permeability after endotoxinProstaglandins, thromboxanes and leukotrienes in clinical medicinePlatelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitorsThe addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice.Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages.Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.Metabolic fate of arachidonic acid in hepatocytes of continuously endotoxemic rats.Indomethacin potentiates endotoxin-induced blood flow reduction and histological injury in rat gastric mucosaThe role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbitsIncreased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapyProstaglandins and thromboxane in the delayed phase of shock induced by Serratia marcescens endotoxin.Role of prostaglandins in tumour necrosis factor induced weight lossNeutropenia induced by systemic infusion of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid: correlation with its in vitro effects upon neutrophils.Ibuprofen in canine endotoxin shockBiological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharidesPrevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet.Lipid X protects mice against fatal Escherichia coli infection.Prostacyclin reversal of lethal endotoxemia in dogs.Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogsLipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.The biology, pathophysiology and control of eicosanoids in inflammation.Animal studies of toxic shock syndrome.Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats.In vivo and in vitro effects of endotoxin on prostaglandin release from rat lung.Introduction: thromboxane in biological systems and the possible impact of its inhibition.Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites.Alpha 2 macroglobulin of the rat, an acute phase protein, mitigates the early course of endotoxin shock.Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.Activation of glomerular mesangial cells by gram-negative bacterial cell wall components.Ascorbate reduces mouse platelet aggregation and surface P-selectin expression in an ex vivo model of sepsis.Tumor necrosis factor causes bronchial hyperresponsiveness in rats.Dibutyryl-cAMP blocks endotoxin-induced lung injury in rats.Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs.
P2860
Q24603093-6DA7DEE6-B015-4510-868C-1CF8DECF8D5AQ33477187-749DB1CC-E2A1-455F-B566-EFF8E6D01F6EQ33477643-021767E1-FB8E-4CAD-A97B-BE4C514C2D22Q33626434-8DF2BBAB-B66B-4D8A-BE64-9CFD5E2FDB42Q33822272-D8F28D6F-5394-4DF8-B1A3-2C589708560EQ34192889-E1149B60-4B5E-4966-A0F0-DC3C5AB4C62FQ34572515-B707F2D7-F52A-4BFE-A94A-844324D4FC97Q34632772-FBCC8865-D26C-478A-99F8-7F841E7113D4Q34778491-DE1E842A-54B3-443D-A099-4F37258A5D3EQ35041523-F76AB42B-545B-4C65-AA9A-23A75D40848FQ35203229-3BBC946F-FA27-4AAE-BBA7-8F3FFED37B9AQ35585970-41352A86-869A-413B-AE2A-DBF99593F60CQ35755443-25EA25C3-2323-40BA-8313-8F4270D0E0E4Q35870616-DE25423C-2CD6-4A55-911F-8A58046B98CBQ35904719-720E63DD-0DAB-487A-B2DC-050C5A780F33Q36004436-599EDB1D-64CB-48A0-9066-1292945EB1F9Q36468091-39D3F7A4-D074-4E97-B5E0-66B235905C74Q36982726-AAC648D1-B644-4FC3-BCBA-971E72B6BCD7Q36985885-9B7FA29F-F826-47A4-840B-BA1AAD823223Q36987114-56ABA3DE-F0C2-4EF9-9AD8-63EAE4842A9BQ36995549-0DE1F56E-5615-4C76-9482-4F60C9586D8FQ36995601-60B31490-9F56-4098-82A7-7BE12FB7E568Q36997700-CD80BFF1-9A87-458D-96D4-78F9897AC9DDQ37002212-EF9A1432-F0FB-4082-985F-89A289CF65A8Q37024140-F2F3E39B-851B-4B42-915B-8EA9F62978C9Q39493756-8AEE0909-ED4F-4870-A375-14A33EDC649EQ39614441-DC2DBE66-670C-4372-B219-527B8DB09472Q39866555-A50E0222-13D3-4DF5-9184-FC675DDAB3DDQ39928677-C8D04162-EE44-42F0-91FA-842E398549C4Q40144735-AEEBDB2D-F4E6-4C29-85FD-975E907CA44CQ41203775-A9A55512-BE02-461B-B741-38F47B9296B3Q41558339-488B7303-DE9E-46C9-BC22-58A48A288C70Q42050277-ADCCFB36-366E-4FFE-8F24-1D4EBDDC2635Q42054865-98F46049-3B1D-4B3D-BD47-26FD084A35B5Q42767493-61A4D226-7410-44D8-B5A6-A8EFFCF31E1CQ44098585-50CCF1F0-5B40-4079-9843-1A0295C4CAA0Q44810680-09C38C20-3A04-4712-A547-5A41D11ED9E8Q45093467-8A0CF364-CCB9-4330-9622-BDE85ECE4DBAQ46086615-71D4EDCD-4026-477B-BF51-DAF10327ACBF
P2860
Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1980
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated thromboxane levels in ...... sential fatty acid deficiency.
@en
Elevated thromboxane levels in ...... sential fatty acid deficiency.
@nl
type
label
Elevated thromboxane levels in ...... sential fatty acid deficiency.
@en
Elevated thromboxane levels in ...... sential fatty acid deficiency.
@nl
prefLabel
Elevated thromboxane levels in ...... sential fatty acid deficiency.
@en
Elevated thromboxane levels in ...... sential fatty acid deficiency.
@nl
P2093
P2860
P356
P1476
Elevated thromboxane levels in ...... sential fatty acid deficiency.
@en
P2093
P2860
P304
P356
10.1172/JCI109655
P407
P577
1980-01-01T00:00:00Z